Introduction
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analogue of native IGF-1 widely used in preclinical research. Its extended half-life and potent anabolic signaling make it one of the most studied compounds in muscle biology, cell proliferation, and metabolic research. This guide covers the essential information researchers need when working with IGF-1 LR3.
What Is IGF-1 LR3?
IGF-1 LR3 is a recombinant analogue of human IGF-1 with two structural modifications: an arginine substitution at position 3 and a 13-amino acid extension at the N-terminus. These changes dramatically reduce its binding affinity for IGF-binding proteins (IGFBPs), which normally sequester IGF-1 in the bloodstream and limit its bioavailability. As a result, IGF-1 LR3 has a half-life of approximately 20 to 30 hours compared to native IGF-1’s half-life of minutes.
Mechanism of Action
IGF-1 LR3 acts primarily through the IGF-1 receptor (IGF-1R), a tyrosine kinase receptor that activates downstream signaling pathways including PI3K/Akt and MAPK/ERK. These pathways regulate cell survival, proliferation, differentiation, and protein synthesis. In muscle tissue research, IGF-1 LR3 has been shown to activate satellite cells — the resident stem cells responsible for muscle repair and hypertrophy.
Research Applications
Primary research applications include skeletal muscle cell proliferation and differentiation studies, satellite cell activation research, metabolic signaling pathway investigations, cancer biology research (IGF-1R is overexpressed in many tumor types), and aging research where IGF-1 axis decline is a studied variable.
Handling and Reconstitution
IGF-1 LR3 is supplied as a lyophilized powder and requires careful reconstitution. It is typically dissolved in dilute acetic acid (1% acetic acid) rather than plain BAC water, as this improves initial solubility. The solution can then be diluted further with sterile PBS or BAC water to the desired working concentration. IGF-1 LR3 is sensitive to agitation — never vortex or shake the solution.
Storage Requirements
Lyophilized IGF-1 LR3 should be stored at -20°C and is stable for up to 12 months under these conditions. Reconstituted IGF-1 LR3 should be stored at 4°C and used within 3 weeks. Avoid repeated freeze-thaw cycles. Due to its protein nature, IGF-1 LR3 is more susceptible to degradation than smaller peptides and requires particularly careful handling.
Concentration and Dosing in Research
Research protocols vary considerably. In cell culture studies, IGF-1 LR3 is typically used at concentrations of 10 to 100 ng/mL. Animal study protocols reference a wide range depending on the model and endpoint being studied. Researchers should consult the primary literature for species-specific and application-specific protocol guidance.
Conclusion
IGF-1 LR3 is a powerful and widely used research tool for studying anabolic signaling, muscle biology, and cell proliferation. Its extended half-life and high receptor affinity make it particularly valuable for in vitro and in vivo studies where sustained IGF-1 pathway activation is required. Proper handling and storage are essential given its sensitivity to degradation.